9 Cardiology Headlines You Missed in July 2025

Cardiology saw a flurry of activity from the US Food and Drug Administration (FDA) in July 2025, with new approvals, label expansions, and regulatory updates reflecting a dynamic treatment and increasing emphasis on personalized care across several forms of cardiovascular disease, including heart failure, lipid disorders, arrhythmias, and cardiometabolic disease.